Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy. [electronic resource]
Producer: 19890627Description: 704-9 p. digitalISSN:- 0012-1797
- Adult
- Blood Glucose -- metabolism
- Circadian Rhythm
- Clinical Trials as Topic
- Diabetes Mellitus, Type 1 -- blood
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Glucagon -- blood
- Glycated Hemoglobin -- analysis
- Growth Hormone -- blood
- Humans
- Insulin -- blood
- Lipids -- blood
- Male
- Octreotide -- adverse effects
- Random Allocation
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.